Estrogen receptor distribution in the peripheral, intermediate and central regions of breast cancers.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  European Journal of Cancer and Clinical Oncology

• Publication date

  1988-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0277-5379(88)90102-2PMID 3220085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of molybdate on the intracellular distribution of estrogen receptor in mammary tumors

  2005cited by this paper
• High-performance hydrophobic interaction chromatography of estrogen receptors and magnesium dependent protein kinase(s): detection of two molecular forms of estrogen receptors in the presence and absence of sodium molybdate.

  1988cited by this paper
• Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies.

  1987cited by this paper
• Subunit composition of the molybdate-stabilized "8-9 S" nontransformed estradiol receptor purified from calf uterus.

  1987cited by this paper
• Multiple microsample analysis of intratumor estrogen receptor distribution in breast cancers by a combined biochemical/immunohistochemical method.

  1987cited by this paper
• Hormone-free estrogen receptors in target cell nuclei: a commentary.

  1986cited by this paper
• Heterogeneous estrogen receptor levels detected via multiple microsamples from individual breast cancers

  1985cited by this paper
• Effects of temperature, storage and sodium molybdate on the analysis of estrogen and progesterone receptors in rabbit uterine tissue and gynecologic tumor.

  1984cited by this paper
• Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor.

  1984cited by this paper
• Effect of sodium molybdate on cytosolic estrogen receptor.

  1982cited by this paper
• Estrogen receptor assay on breast cancer microsamples: Implications of percent carcinoma estimation

  1982cited by this paper
• Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma.

  1980cited by this paper
• Electrophoretic assay of specific estrogen receptors: a contribution to methodology.

  1977cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival

  2018cites this paper
• Bivalent Approach for Homodimeric Estradiol Based Ligand: Synthesis and Evaluation for Targeted Theranosis of ER(+) Breast Carcinomas.

  2016cites this paper
• Alternative synthesis for the preparation of 16α-[(18) F]fluoroestradiol.

  2013cites this paper
• Risk factors and novel biomarkers in breast cancer

  2011cites this paper
• DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery

  2010cites this paper
• Effect of Tamoxifen on the Multidrug-resistant Phenotype in Human Breast Cancer Cells : Isobologram , Drug Accumulation , and Mr 170 , 000 Glycoprotein ( gpl 70 ) Binding Studies 1

  2007cites this paper
• Targeted functional imaging of estrogen receptors with 99mTc-GAP-EDL

  2007cites this paper
• Targeted functional imaging in breast cancer

  2007cites this paper
• Molecular Mechanism of Nucleotide Excision Repair Deficiency in Novel Breast Cancer Cell Lines

  2006cites this paper
• with llß-Methoxy-(17a,20Z)-[123I]Iodovinylestradiol:A Complementary Role to 99mTc-Methoxyisobutyl Isonitrile in the Characterization of Breast Tumors

  2006cites this paper
• In vivo prediction of response to antiestrogen treatment in estrogen receptor-positive breast cancer.

  2004cites this paper
• Radiation as A Cure for Cancer: The History of Radiation Treatment in British Columbia

  2003cites this paper
• Synthesis of 16α-fluoro ICI 182,780 derivatives: powerful antiestrogens to image estrogen receptor densities in breast cancer by positron emission tomography

  2002cites this paper
• Synthesis of 2,16α- and 4,16α-difluoroestradiols and their 11β-methoxy derivatives as potential estrogen receptor-binding radiopharmaceuticals

  2002cites this paper
• 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals.

  2002cites this paper
• Molecular Mechanisms of Estrogen and Antiestrogen Resistance

  2001cites this paper
• Estrogen receptor status in primary breast cancer: iodine 123-labeled cis-11beta-methoxy-17alpha-iodovinyl estradiol scintigraphy.

  2001cites this paper
• Molecular and pharmacological aspects of antiestrogen resistance.

  2001cites this paper
• Scintimammography with 11beta-methoxy-(17alpha,20Z)-[123I]iodovinylestrad iol: a complementary role to 99mTc-methoxyisobutyl isonitrile in the characterization of breast tumors.

  2000cites this paper
• (17α,20E/Z)-iodovinyl- and 16α-iodo-18-homoestradiol derivatives: synthesis and evaluation for estrogen receptor imaging

  2000cites this paper
• 18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG.

  2000cites this paper
• 18 F-labeled Radiopharmaceuticals for PET in Oncology,

  2000cites this paper
• (17alpha,20E/Z)-iodovinyl- and 16alpha-iodP618-homoestradiol derivatives: synthesis and evaluation for estrogen receptor imaging.

  2000cites this paper
• Biodistribution, dosimetry and metabolism of 11beta-methoxy-(17alpha,20E/Z)-[123I]iodovinylestradiol in healthy women and breast cancer patients.

  1999cites this paper
• New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization.

  1998cites this paper
• New Approaches to the Labeling of Estrogens Useful for PET (Predoctral Training Program).

  1998cites this paper
• PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.

  1998cites this paper
• Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE.

  1997cites this paper
• Steroid Hormone Receptors Related to Parameters Characterizing the Biology of Human Breast Cancer

  1997cites this paper
• MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.

  1997cites this paper
• The Z-isomer of 11 beta-methoxy-17 alpha-[123I]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancer.

  1997cites this paper
• The Z-isomer of 11β-methoxy-17α-[123I]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancer☆

  1997cites this paper
• Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging

  1997cites this paper
• Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms.

  1996cites this paper
• Immunohistochemically Determined Estrogen and Progesterone Receptor Levels: A Comparison of Three Antibodies with the Ligand‐Binding Assay

  1996cites this paper
• The stereoisomers of 17α-[123I]iodovinyloestradiol and its 11α-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats

  1996cites this paper
• Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies.

  1994cites this paper
• Influence of mastectomy techniques on estrogen and progesterone receptor analysis in carcinoma of the breast.

  1993cites this paper
• Hormone resistance, invasiveness, and metastatic potential in breast cancer

  1993cites this paper
• Improvement of the quantification of estrogen and progesterone receptors in paraffin-embedded tumors by image analysis.

  1993cites this paper
• Heterogenic properties of clonal cell lines derived from canine mammary carcinomas and sensitivity to tamoxifen and doxorubicin.

  1993cites this paper
• Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions.

  1992cites this paper
• Positron Tomographic Assessment of 16α-[18F] Fluoro-17β-Estradiol Uptake in Metastatic Breast Carcinoma

  1991cites this paper
• Steroid receptors in breast cancer

  1991cites this paper
• Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.

  1991cites this paper
• Quantification of estrogen receptors on paraffin-embedded tumors by image analysis.

  1991cites this paper
• The process of malignant progression in human breast cancer.

  1990cites this paper
• Breast carcinoma cellularity and estrogen receptors.

  1990cites this paper
• Misleading statement about serum ferritin.

  1990cites this paper
• Nucleolar organiser regions in renal tumours.

  1990cites this paper
• Cellularity and oestrogen receptor content in breast cancer microsamples.

  1990cites this paper
• An apparatus to retain the spatial orientation of breast biopsies.

  1989cites this paper
• DAMD 1794-J-402 9 TITLE : New Approaches to the Labeling of Estrogens Useful for PET ( Predoctral Training Program ) PRINCIPAL INVESTIGATOR :

  year unknowncites this paper